Hans Prenen
Impact in
- Gastroenterology top 0.5%
- Gastrointestinal Tumor Research and Treatment
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 123
- Colorectal Cancer Treatments and Studies 54
- Cancer Immunotherapy and Biomarkers 25
- Cancer Cells and Metastasis 13
-
- Gastric Cancer Management and Outcomes 23
- Lung Cancer Treatments and Mutations 18
- Co-authors
- Eric Van Cutsem (45 shared papers)Xavier Sagaert (11 shared papers)Baki Topal (8 shared papers)Karin Haustermans (3 shared papers)Massimiliano Mazzone (13 shared papers)Maria Dêbiec‐Rychter (9 shared papers)Mario Di Matteo (5 shared papers)Raf Sciot (10 shared papers)
- Journals
- Journal of Clinical Oncology (29 papers)Annals of Oncology (24 papers)Critical Reviews in Oncology/Hematology (6 papers)Clinical Cancer Research (6 papers)British Journal of Cancer (4 papers)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
Hans Prenen
201 papers receiving 8.8k citations
Hans Prenen's Hit Papers
Peers
Comparison fields: 5 of 135
- Gastroenterology 827
- Oncology 3.4k
- Cancer Research 1.3k
- Hepatology 509
- Pulmonary and Respiratory Medicine 2.0k
Countries citing papers authored by Hans Prenen
This map shows the geographic impact of Hans Prenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Prenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Prenen more than expected).
Fields of papers citing papers by Hans Prenen
This network shows the impact of papers produced by Hans Prenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Prenen. The network helps show where Hans Prenen may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans Prenen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gastric cancer Hit paper breakdown → | 2016 | 1471 |
| 2 | Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen Hit paper breakdown → | 2012 | 1039 |
| 3 | 2005 | 415 | |
| 4 | 2016 | 404 | |
| 5 | MET is required for the recruitment of anti-tumoural neutrophils Hit paper breakdown → | 2015 | 389 |
| 6 | 2019 | 286 | |
| 7 | 2009 | 246 | |
| 8 | 2006 | 240 | |
| 9 | 2019 | 180 | |
| 10 | 2016 | 175 | |
| 11 | 2006 | 167 | |
| 12 | Molecular genetics of colorectal cancer. | 2014 | 145 |
| 13 | 2016 | 131 | |
| 14 | 2006 | 117 | |
| 15 | 2015 | 107 | |
| 16 | 2017 | 100 | |
| 17 | 2013 | 99 | |
| 18 | 2014 | 95 | |
| 19 | 2008 | 95 | |
| 20 | 2014 | 89 |
About Hans Prenen
Hans Prenen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Cancer Research, having authored 208 papers that have together received 9.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (54 papers), Cancer Immunotherapy and Biomarkers (25 papers), Gastric Cancer Management and Outcomes (23 papers), Lung Cancer Treatments and Mutations (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cancer Genomics and Diagnostics (15 papers), Gastrointestinal Tumor Research and Treatment (14 papers) and Cancer Cells and Metastasis (13 papers). The work is most often cited by research in Gastroenterology (827 citations), Oncology (3.4k citations), Cancer Research (1.3k citations), Hepatology (509 citations) and Pulmonary and Respiratory Medicine (2.0k citations). Hans Prenen has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Eric Van Cutsem, Xavier Sagaert, Baki Topal, Karin Haustermans, Massimiliano Mazzone, Maria Dêbiec‐Rychter, Mario Di Matteo, Raf Sciot, Josep Tabernero and A. van Oosterom. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Critical Reviews in Oncology/Hematology, Clinical Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.